ETFdb Logo
ETFdb Logo
  • ETF Database
  • Channels
    • Active ETF
    • Beyond Basic Beta
    • China Insights
    • Climate Insights
    • Commodities
    • Core Strategies
    • Crypto
    • Disruptive Technology
    • Energy Infrastructure
    • ETF Building Blocks
    • ETF Education
    • ETF Strategist
    • Fixed Income
    • Free Cash Flow
    • Gold/Silver/Critical Minerals
    • Innovative ETFs
    • Institutional Income Strategies
    • Leveraged & Inverse
    • Managed Futures
    • Market Insights
    • Modern Alpha
    • Night Effect
    • Portfolio Strategies
    • Retirement Income
    • Richard Bernstein Advisors
    • Tax Efficient Income
    • Volatility Resource
  • Tools
    • ETF Screener
    • ETF Country Exposure Tool
    • ETF Sector Tracker Tool
    • ETF Database Categories
    • Head-To-Head ETF Comparison Tool
    • ETF Stock Exposure Tool
    • ETF Issuer Fund Flows
    • Indexes
    • Mutual Fund To ETF Converter
  • Research
    • ETF Education
    • Equity Investing
    • Dividend ETFs
    • Leveraged ETFs
    • Inverse ETFs
    • Index Education
    • Index Insights
    • Top ETF Sectors
    • Top ETF Issuers
    • Top ETF Industries
  • Webcasts
  • Themes
    • AI ETFs
    • Blockchain ETFs
    • See all Thematic Investing ETF themes
    • ESG Investing
    • Marijuana ETFs
  • Multimedia
    • ETF 360 Video Series
    • ETF of the Week Podcast
    • ETF Prime Podcast
    • Video
  • Company
    • About VettaFi
    • Get VettaFi’ed
  • PRO
    • Pro Content
    • Pro Tools
    • Advanced
    • FAQ
    • Pricing
    • Free Sign Up
    • Login
  1. The Responsible Investing Channel
  2. A Healthcare ETF With a Healthy Outlook
The Responsible Investing Channel
Share

A Healthcare ETF With a Healthy Outlook

Tom LydonJan 26, 2023
2023-01-26

With the S&P 500 Health Care Index lower by 1.43% year-to-date, it’s fair to say healthcare isn’t among the sectors rebounding in 2023’s early innings. However, upon closer inspection, some corners of the group are starting the year in strong form.

Medical devices, historically one of the growthier and more durable corners of the healthcare sector, are delivering for investors. Just look at the SPDR S&P Health Care Equipment ETF (XHE A-), which is higher by nearly 6% since the start of 2023.

While the medical device industry isn’t 100% immune to macroeconomic risk, as was on display in 2022, it has some advantages, including price power and its status as a disruptive corner of the wider healthcare arena. Additionally, some analysts are constructive on the industry for 2023.

“Based on commentary, the broader environment seems to be gradually improving, and early 4Q pre-announcements have mostly been above consensus,” wrote KeyBanc Capital Markets analyst Matthew Mishan in a note to clients. “We continue to believe in a MedTech investment thesis of relatively recession-resilient sales.”

The $399.47 million XHE turns 12 years old later this week and follows the S&P Health Care Equipment Select Industry Index. That index is pertinent to investors considering this exchange traded fund because it equally weights the fund’s 78 holdings. That diminishes single-stock risk, but that might not be a primary concern at a time when analysts are forecasting upside for several XHE components.

That group includes Paragon 29 Inc. (FNA), a small-cap firm that hasn’t even been public for two years. The company recently delivered preliminary fourth-quarter results, indicating it could top Wall Street’s revenue outlook by as much as 20%.

“The company specializes in plating and bone graft systems to treat ankle and orthopedic problems. While not widely followed, all six of the analysts covering the stock rate it a buy, according to FactSet. The mean price target implies nearly 50% upside over the next 12 months,” reported Bertha Coombs for CNBC.

Shockwave Medical (SWAV), a producer of devices used to treat hard arteries, is another XHE component analysts like.

The company “told analysts last week that is confident that one of its marquee products will receive the highest tier Medicare reimbursement rate of $17,000 in coming months; the company is in discussions with the Centers for Medicare and Medicaid,” according to CNBC. “More than 60% of analysts rate the shares a buy, with a mean price target implying 34% upside.”

For more news, information, and analysis, visit the ESG Channel.

Loading Articles...
Help & Info
  • Contact Us
Tools
  • ETF Screener
  • ETF Analyzer
  • Mutual Fund to ETF Converter
  • Head-To-Head ETF Comparison
  • ETF Country Exposure Tool
  • ETF Stock Exposure Tool
  • ETF Performance Visualizer
  • ETF Database Model Portfolios
  • ETF Database Realtime Ratings
  • ETF Database Pro
More Tools
  • ETF Launch Center
  • Financial Advisor & RIA Center
  • ETF Database RSS Feed
Explore ETFs
  • ETF News
  • ETF Picks of the Month
  • ETF Category Reports
  • Premium Articles
  • Alphabetical Listing of ETFs
  • Best ETFs
  • Browse ETFs by ETF Database Category
  • Browse ETFs by Index
  • Browse ETFs by Issuer
  • Compare ETFs
Legal
  • Terms of Use and Privacy Policy
  • © 2023 VettaFi LLC. All rights reserved.
Follow ETF Database
Follow ETF Database

Advertisement

Is Your Portfolio Positioned With Enough Global Exposure?

ETF Education Channel

How to Allocate Commodities in Portfolios

Tom LydonApr 26, 2022
2022-04-26

A long-running debate in asset allocation circles is how much of a portfolio an investor should...

Core Strategies Channel

Why ETFs Experience Limit Up/Down Protections

Karrie GordonMay 13, 2022
2022-05-13

In a digital age where information moves in milliseconds and millions of participants can transact...

}
X